MEI Pharma bets $100m on Litecoin as Charlie Lee joins board

2025/07/18 23:49

The Nasdaq-listed biotech firm is making an unprecedented pivot into crypto, committing $100 million to a Litecoin treasury strategy, with the coin’s creator, Charlie Lee, now at the helm.

In a press release dated July 18, the Litecoin Foundation announced that Nasdaq-listed biotech firm MEI Pharma has committed $100 million to a dedicated Litecoin (LTC) treasury strategy, with crypto investment firms Titan Partners and GSR leading the private placement.

The move marks one of the largest corporate allocations to Litecoin to date and comes with a major twist: Charlie Lee, Litecoin’s creator, will join MEI Pharma’s board of directors. The Litecoin Foundation has also taken a stake in the company, signaling a rare convergence of biotech and blockchain.

MEI Pharma’s Litecoin Bet

MEI Pharma’s $100 million Litecoin treasury play can be seen as a strategic alignment with a cryptocurrency that has quietly dominated real-world payments while larger assets like Bitcoin and Ethereum grabbed headlines.

According to the announcement, the decision was driven by Litecoin’s reliability as a low-cost, high-speed transactional network, particularly in cross-border payments and retail integrations. Platforms like BitPay, where Litecoin consistently processes more transactions than Bitcoin, demonstrate its utility beyond speculative trading.

“This partnership with GSR and MEI Pharma brings that utility and mission into an institutional setting for the first time,” said Charlie Lee, whose board appointment underscores the long-term vision behind the move.

Unlike Bitcoin, which has become a macro hedge for corporations, or Ethereum, favored for its smart contract capabilities, Litecoin offers something different: a battle-tested payment rail with minimal fees and near-instant settlement.

For a company like MEI Pharma, which may need to move capital efficiently across global markets, this functionality could prove more valuable than price appreciation alone.

The Litecoin Foundation’s direct investment in MEI Pharma further cements the partnership’s strategic nature. Rather than a passive treasury allocation, this is a deliberate integration into Litecoin’s broader adoption push. 

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bloomberg Analysts See 95% Chance of Solana, Litecoin, XRP ETF Approvals This Year

Bloomberg Analysts See 95% Chance of Solana, Litecoin, XRP ETF Approvals This Year

Bloomberg ETF analysts have sharply raised expectations for US approval of spot exchange-traded funds tracking Solana, Litecoin, and XRP, now pegging the odds at 95%. Key Takeaways: Analysts see a 95% chance of Solana, XRP, and Litecoin ETFs being approved by the SEC this year. A crypto index ETF could gain approval as soon as this week, signaling broader institutional access to altcoins. The first US Solana staking ETF will launch Wednesday, but Ethereum staking ETF approvals remain delayed. In an X post on June 1 , ETF specialists Eric Balchunas and James Seyffart said they see a wave of new crypto ETFs hitting the market in the second half of 2025, lifting previous approval odds from 90% to near certainty for these three altcoins. The analysts also assigned 95% odds to the approval of an ETF tracking a basket of crypto assets, hinting at broader institutional access to altcoins. Crypto Index ETF Approval Could Arrive This Week: Bloomberg While the SEC’s final deadline for decisions on Solana, XRP, and Litecoin ETFs arrives in October, a crypto index ETF could secure approval as soon as this week, the pair noted. Other altcoins could also see ETF products soon, though with slightly lower odds. Balchunas and Seyffart forecast 90% approval chances for Dogecoin, Cardano, Polkadot, Hedera, and Avalanche spot ETFs, with SEC decisions expected by year-end. ETFs proposed by Canary Capital for Sui and Tron faced more uncertainty, with approval odds set at 60% and 50% respectively. Trying to figure out what could go into an SEC framework aside from CFTC approved futures we looked at a few potential data points. The entire note and our midyear outlook can be seen at this link for Bloomberg Terminal clients: https://t.co/7C0bO3oEI3 pic.twitter.com/Y9CcCdNAGF — James Seyffart (@JSeyff) June 30, 2025 Adding to the momentum, Bloomberg reported Monday that the REX Osprey Solana Staking ETF will officially launch on Wednesday, marking the first US-listed fund to incorporate crypto staking. The ETF cleared regulatory hurdles after issuers agreed to invest at least 40% of assets in other exchange-traded products, mainly based overseas, to address SEC concerns over its investment company status. Despite progress on altcoin ETFs, Ethereum staking remains on hold. On Monday, the SEC delayed its decision on whether Bitwise’s proposed spot Ether ETF could include staking, and similarly postponed a decision on the Osprey Bitcoin Trust’s listing and trading plans. 70 Crypto ETFs Waiting Approval In April, Bloomberg analyst Eric Balchunas revealed that more than 70 cryptocurrency ETFs are currently awaiting review by the SEC. The lineup features a broad range of digital assets beyond Bitcoin, including XRP, Litecoin, Solana, Dogecoin, and various crypto derivatives. According to Balchunas, spot ETF applications for XRP and Solana are among the most popular in the current wave, with 10 institutions applying for XRP-based ETFs and six for Solana. As reported, digital asset investment funds pulled in $2.7 billion last week, capping an 11-week streak of inflows that now totals $16.9 billion. The bulk of the inflows came from the United States, accounting for $2.65 billion. Switzerland and Germany recorded modest additions of $23 million and $19.8 million, respectively, while Canada, Hong Kong, and Brazil posted small outflows. Bitcoin remained the primary magnet for capital, drawing $2.2 billion last week, a commanding 83% of total inflows, while short-Bitcoin products extended their year-to-date outflows to $12 million, signaling broad optimism for Bitcoin’s prospects. Ethereum followed with $429 million in inflows, boosting its yearly total to $2.9 billion, whereas Solana has attracted just $91 million so far this year, highlighting a significant gap in investor confidence.
Share
CryptoNews2025/07/01 14:17